AURA-LV study of voclosporin in lupus nephritis meets 48-week remission endpoints March 3, 2017 No Comments
Reata initiates phase II/III study of bardoxolone methyl to treat Alport syndrome-associated CKD Feb. 24, 2017 No Comments
Revive Therapeutics and InMed in term sheet agreement for cannabinoid therapies for kidney diseases Feb. 23, 2017 No Comments
Ionis Pharmaceuticals earns milestone from Bayer for advancing antisense drugs Feb. 15, 2017 No Comments
RSS